[3-hydroxy-1-[6-methyl-3-oxo-2-(2-oxo-2-pyrrolidin-1-ylethyl)-2,5-diazaspiro[3.4]octan-5-yl]-1-oxobutan-2-yl]carbamic acid

C18H28N4O6 — CID 135146413

IUPAC[3-hydroxy-1-[6-methyl-3-oxo-2-(2-oxo-2-pyrrolidin-1-ylethyl)-2,5-diazaspiro[3.4]octan-5-yl]-1-oxobutan-2-yl]carbamic acid
SMILESCC(O)C(NC(=O)O)C(=O)N1C(C)CCC12CN(CC(=O)N1CCCC1)C2=O
InChIInChI=1S/C18H28N4O6/c1-11-5-6-18(22(11)15(25)14(12(2)23)19-17(27)28)10-21(16(18)26)9-13(24)20-7-3-4-8-20/h11-12,14,19,23H,3-10H2,1-2H3,(H,27,28)
InChIKeyGEQGVZDHOMPBFF-UHFFFAOYSA-N
MW396.44 g/mol
LogP-0.78
Rot. Bonds5

About [3-hydroxy-1-[6-methyl-3-oxo-2-(2-oxo-2-pyrrolidin-1-ylethyl)-2,5-diazaspiro[3.4]octan-5-yl]-1-oxobutan-2-yl]carbamic acid

[3-hydroxy-1-[6-methyl-3-oxo-2-(2-oxo-2-pyrrolidin-1-ylethyl)-2,5-diazaspiro[3.4]octan-5-yl]-1-oxobutan-2-yl]carbamic acid (PubChem CID 135146413) has the molecular formula C18H28N4O6 and a molecular weight of 396.44 g/mol. Its IUPAC name is [3-hydroxy-1-[6-methyl-3-oxo-2-(2-oxo-2-pyrrolidin-1-ylethyl)-2,5-diazaspiro[3.4]octan-5-yl]-1-oxobutan-2-yl]carbamic acid.

Molecular Properties

Compound Name[3-hydroxy-1-[6-methyl-3-oxo-2-(2-oxo-2-pyrrolidin-1-ylethyl)-2,5-diazaspiro[3.4]octan-5-yl]-1-oxobutan-2-yl]carbamic acid
PubChem CID135146413
Molecular FormulaC18H28N4O6
Molecular Weight396.44 g/mol
Exact Mass396.20
IUPAC Name[3-hydroxy-1-[6-methyl-3-oxo-2-(2-oxo-2-pyrrolidin-1-ylethyl)-2,5-diazaspiro[3.4]octan-5-yl]-1-oxobutan-2-yl]carbamic acid
SMILESCC(O)C(NC(=O)O)C(=O)N1C(C)CCC12CN(CC(=O)N1CCCC1)C2=O
InChIInChI=1S/C18H28N4O6/c1-11-5-6-18(22(11)15(25)14(12(2)23)19-17(27)28)10-21(16(18)26)9-13(24)20-7-3-4-8-20/h11-12,14,19,23H,3-10H2,1-2H3,(H,27,28)
InChIKeyGEQGVZDHOMPBFF-UHFFFAOYSA-N
XLogP-0.78
TPSA130.49 Ų
H-Bond Donors3
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500396.44
LogP ≤ 5-0.78
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 105

Analyze [3-hydroxy-1-[6-methyl-3-oxo-2-(2-oxo-2-pyrrolidin-1-ylethyl)-2,5-diazaspiro[3.4]octan-5-yl]-1-oxobutan-2-yl]carbamic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [3-hydroxy-1-[6-methyl-3-oxo-2-(2-oxo-2-pyrrolidin-1-ylethyl)-2,5-diazaspiro[3.4]octan-5-yl]-1-oxobutan-2-yl]carbamic acid?
The IUPAC name of [3-hydroxy-1-[6-methyl-3-oxo-2-(2-oxo-2-pyrrolidin-1-ylethyl)-2,5-diazaspiro[3.4]octan-5-yl]-1-oxobutan-2-yl]carbamic acid (CID 135146413) is [3-hydroxy-1-[6-methyl-3-oxo-2-(2-oxo-2-pyrrolidin-1-ylethyl)-2,5-diazaspiro[3.4]octan-5-yl]-1-oxobutan-2-yl]carbamic acid.
What is the SMILES notation for [3-hydroxy-1-[6-methyl-3-oxo-2-(2-oxo-2-pyrrolidin-1-ylethyl)-2,5-diazaspiro[3.4]octan-5-yl]-1-oxobutan-2-yl]carbamic acid?
The canonical SMILES for [3-hydroxy-1-[6-methyl-3-oxo-2-(2-oxo-2-pyrrolidin-1-ylethyl)-2,5-diazaspiro[3.4]octan-5-yl]-1-oxobutan-2-yl]carbamic acid is CC(O)C(NC(=O)O)C(=O)N1C(C)CCC12CN(CC(=O)N1CCCC1)C2=O.
What is the InChIKey of [3-hydroxy-1-[6-methyl-3-oxo-2-(2-oxo-2-pyrrolidin-1-ylethyl)-2,5-diazaspiro[3.4]octan-5-yl]-1-oxobutan-2-yl]carbamic acid?
The InChIKey is GEQGVZDHOMPBFF-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H28N4O6/c1-11-5-6-18(22(11)15(25)14(12(2)23)19-17(27)28)10-21(16(18)26)9-13(24)20-7-3-4-8-20/h11-12,14,19,23H,3-10H2,1-2H3,(H,27,28).
What are the key properties of [3-hydroxy-1-[6-methyl-3-oxo-2-(2-oxo-2-pyrrolidin-1-ylethyl)-2,5-diazaspiro[3.4]octan-5-yl]-1-oxobutan-2-yl]carbamic acid?
[3-hydroxy-1-[6-methyl-3-oxo-2-(2-oxo-2-pyrrolidin-1-ylethyl)-2,5-diazaspiro[3.4]octan-5-yl]-1-oxobutan-2-yl]carbamic acid has a molecular weight of 396.44 g/mol, XLogP of -0.78, 5 rotatable bonds, 3 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [3-hydroxy-1-[6-methyl-3-oxo-2-(2-oxo-2-pyrrolidin-1-ylethyl)-2,5-diazaspiro[3.4]octan-5-yl]-1-oxobutan-2-yl]carbamic acid is sourced from PubChem (CID 135146413), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).